Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT02293733
Eligibility Criteria:
Eligibility criteria:
* Inclusion criteria:
* NSCLC patients with activating mutations of EGFR
* First-line treatment with a TKI monotherapy
* Measurable lesion according to RECIST 1.1
* Age\> 18 years
* secondary or acquired resistance of EGFR TKIs according to the jackman criteria
* patients for whom it was started a TKI treatment in first line from January 2010 until June 2012 (patients who received 1 Chemotherapy cycle could be included).
* Exclusion criteria:
* Patients with small cell carcinoma
* Patients without EGFR mutation
* Patients not treated with EGFR TKI in first line treatment
* Not measurable lesion to RECIST 1.1
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02293733
Study Brief:
Protocol Section:
NCT02293733